BCPC

$162.01-2.28 (-1.39%)

Market ClosedAs of Mar 20, 8:00 PM UTC

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide.

Historical Price

Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$162.01
Potential Downside
40.6%
Whystock Fair Value$96.29
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorBasic Materials
IndustrySpecialty Chemicals

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It opera...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$5.25B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
34.11
Beta
Defensive asset. Lower volatility than the S&P 500.
0.94
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
11.35%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
1.33

Recent News

Simply Wall St.
Mar 21, 2026

Should Balchem’s New T.E.A.M. Platform Reframe Its Data Advantage Narrative for Investors (BCPC)?

Earlier this month, Balchem Plant Nutrition launched Metalosate T.E.A.M., a free digital platform that turns plant tissue analysis into actionable nutrition recommendations for U.S. advisors working with specialty crops such as tree nuts, fruits, berries, and vines. By converting raw micronutrient data into prioritized, research-based prescriptions and storing historical results, T.E.A.M. gives agronomists a structured way to improve yield potential, crop quality, and input efficiency over...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 20, 2026

Kinross Gold Unveils New NCIB Program to Buy Back Up to 104.2M Shares

KGC renews share buyback program, targeting up to 10% of float, as Kinross bets its valuation undervalues the business.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 20, 2026

Nucor Sees Stronger Q1 Earnings on Steel Mills Unit Gains

Nucor projects Q1 EPS jumping to $2.70-$2.80 as segment gains drive improved profitability.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 19, 2026

SMG Ties Up With Bonnie Plants & Gardenuity to Launch Inspired to Gro

SMG teams up with Bonnie Plants and Gardenuity to launch a beginner-friendly patio garden kit, tapping rising interest in homegrown food and sustainability.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 19, 2026

Huntsman Inaugurates Operational Unit Expansion in Hungary

HUN expands Hungary facility, boosting capacity and innovation to meet rising catalyst demand and support energy-saving, low-emission products.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.